Viewing StudyNCT00510939



Ignite Creation Date: 2024-05-05 @ 6:38 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00510939
Status: UNKNOWN
Last Update Posted: 2009-08-14
First Post: 2007-08-02

Brief Title: Study to Assess the Safety Tolerability and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Acute Myeloid Leukemia
Sponsor: University of Bologna
Organization: University of Bologna

Organization Data

Organization: University of Bologna
Class: OTHER
Study ID: HEMOS AML 0106
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of Bologna
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Giovanni Martinelli
Old Organization: Dipartimento di Ematologia Seragnoli- Policlinico SantOrsola Bologna

Collaborators

Name Class
Janssen-Cilag Ltd INDUSTRY